Search Results
Sep 02, 2026, 08:30 ET Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
Clinically relevant germline alterations were identified in 12.2% of 3,609 NSCLC patients.Frequently altered genes included MUTYH, CHEK2, ATM, BRCA2 and MITF.Among patients with linked tumor profiling, 45.8% of pathogenic, likely pathogenic or risk germline
More news about: Caris Life Sciences
Aug 04, 2026, 09:10 ET Wildfire and Emergency Response Drones Are Reshaping a Billion-Dollar Market
high-quality fire retardant and firefighting foam, the County is also taking preventative measures to help protect communities from wildfire by applying PHOS-CHEK® long-term fire retardant along all high fire-risk County roads for the sixth consecutive year."Many of my constituents have been personally
More news about: Market News Updates
May 20, 2026, 06:00 ET Discovery Life Sciences Launches IVDR-Compliant Luminos® Comprehensive with 7-to-10-Day Turnaround for EU Oncology Trials
BRAF, PIK3CA, HER2, TP53) sit alongside less-charted targets relevant to next-generation TKI and small-molecule programs, including KEAP1/NFE2L2, ATM/CHEK2, the MLH1/MSH2 mismatch-repair set, and FGFR1-3. The full gene list and pathway coverage are detailed in the technical summary.For sponsors
More news about: Discovery Life Sciences
Apr 09, 2026, 08:58 ET Diabetic Buy Back Celebrates Two-Year Anniversary with Over $5 Million Paid Out and Nearly 100,000 Boxes of Supplies Made Available to Diabetics in Need
via ACH, Zelle, PayPal, Venmo, CashApp, or CheckDiabeticBuyBack.com accepts most major brands including FreeStyle, Dexcom, Omnipod, Accu-Chek, OneTouch, Bayer/Contour, and more.Two Years. Real Impact.$5M+ paid out to sellers nationwide4,500+
More news about: Diabetic Buy Back
Jan 20, 2026, 08:40 ET Two Moms Buy Test Strips Celebrates 10 Years of Making Diabetes Care More Affordable with Major Website Upgrade
afford high retail prices. The BBB-accredited company accepts test strips, CGMs, readers, pumps, and lancets from major brands including Dexcom, Accu-Chek, Omnipod, and Freestyle. For more information, visit www.TwoMomsBuyTestStrips.com.Media
More news about: Two Moms Buy Test Strips
Nov 10, 2025, 11:00 ET Patient Monitoring Devices Market to be Worth $118.21 Billion by 2033 at CAGR of 10.21% - Grand View Research, Inc.
offer continuous, reliable data and predictive insights for proactive care models. A notable example is Roche's July 2024 CE mark approval for its Accu-Chek SmartGuide CGM, a continuous glucose monitoring system integrating AI algorithms to predict hypoglycemia up to 30 minutes in advance, representing a
More news about: Grand View Research, Inc.
Oct 09, 2025, 06:00 ET Allelica Launches AbsoluteDx: The Most Comprehensive Genetic Risk Assessment, Combining Monogenic and Polygenic Insights Across Multiple Diseases
patients may carry the same monogenic mutation (like those in the CHEK2 gene for breast cancer) but have very different absolute risk levels because their breast cancer PRS modulates the penetrance of the mutations in the CHEK2 gene. As such, these patients need to be treated differently. Absolute
More news about: Allelica, Inc.
Oct 07, 2025, 13:22 ET Outubro Rosa: Bioma Genetics alerta para o papel dos exames genéticos na prevenção do câncer de mama e ovário
hereditária para o câncer de mama e ovário. Utilizando tecnologia de sequenciamento de nova geração (NGS), o exame investiga genes como BRCA1, BRCA2, PALB2, CHEK2 e TP53, entre outros reconhecidos pela comunidade científica internacional. Estudos apontam que de 5% a 10% dos casos de câncer
More news about: Bioma Genetics
Sep 17, 2025, 10:30 ET Diabetes Care Devices Market worth US$61.2 billion by 2030 with 12.3% CAGR | MarketsandMarkets™
and solutions for effective diabetes management. A flagship product in this segment is the Accu-Chek blood glucose meter, widely recognized and clinically recommended for blood glucose monitoring. Accu-Chek devices are trusted by both patients and healthcare professionals for their accuracy, reliability,
More news about: MarketsandMarkets
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
the Accu-Chek SmartGuide CGM solutionAccu-Chek SmartGuide is a continuous glucose monitoring (CGM) solution providing accurate real-time glucose readings and AI-enabled predictions for different timeframes. The current version of the solution includes three elements: the Accu-Chek SmartGuide
More news about: Roche
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
the Accu-Chek SmartGuide CGM solutionAccu-Chek SmartGuide is a continuous glucose monitoring (CGM) solution providing accurate real-time glucose readings and AI-enabled predictions for different timeframes. The current version of the solution includes three elements: the Accu-Chek SmartGuide
More news about: Roche